OCT Imaging of Papilledema in Pediatric Idiopathic Intracranial Hypertension
1 other identifier
interventional
50
1 country
1
Brief Summary
Longitudinal clinical observation of optic nerve head, using slit lamp fundoscopy, guides therapy in pediatric idiopathic intracranial hypertension (IIH) patients; however, it remains a limited method of producing quantitative data in evaluating in patients with IIH. In this study we intend to compare, by using spectral domain optical coherence tomography (OCT), the mean retinal nerve fiber layer thickness and total retinal thickness (RNFLT/TRT) of the optic nerve of newly diagnosed IIH children to a control group. This will provide a quantitative measure for follow-up and treatment of this patient group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 24, 2016
CompletedFirst Posted
Study publicly available on registry
January 28, 2016
CompletedStudy Start
First participant enrolled
February 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2017
CompletedJanuary 28, 2016
January 1, 2016
1 year
January 24, 2016
January 24, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Comparison of RNFLT/TRT Thickness
One year
Study Arms (2)
IIH Patients
ACTIVE COMPARATORPatients diagnosed with Idiopathic Intracranial Hypertension who undergo OCT imaging
Control Group
ACTIVE COMPARATORPatients diagnosed with headache with ruled out Idiopathic Intracranial Hypertension who undergo OCT imaging
Interventions
Eligibility Criteria
You may qualify if:
- Children with suspected IIH
You may not qualify if:
- Retinal disease
- High refractive error
- Unable to undergo OCT imaging
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hillel Yaffe Medical Center
Hadera, 38100, Israel
Study Officials
- PRINCIPAL INVESTIGATOR
Yuval Cohen, MD, PhD
Hillel Yaffe Medical Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 24, 2016
First Posted
January 28, 2016
Study Start
February 1, 2016
Primary Completion
February 1, 2017
Study Completion
February 1, 2017
Last Updated
January 28, 2016
Record last verified: 2016-01
Data Sharing
- IPD Sharing
- Will not share